vs

Side-by-side financial comparison of Primis Financial Corp. (FRST) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Primis Financial Corp. is the larger business by last-quarter revenue ($45.6M vs $41.8M, roughly 1.1× Neuronetics, Inc.). Primis Financial Corp. runs the higher net margin — 16.0% vs -17.2%, a 33.3% gap on every dollar of revenue. Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 13.0%).

Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

FRST vs STIM — Head-to-Head

Bigger by revenue
FRST
FRST
1.1× larger
FRST
$45.6M
$41.8M
STIM
Higher net margin
FRST
FRST
33.3% more per $
FRST
16.0%
-17.2%
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
13.0%
FRST

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FRST
FRST
STIM
STIM
Revenue
$45.6M
$41.8M
Net Profit
$7.3M
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
16.0%
-17.2%
Revenue YoY
85.7%
Net Profit YoY
200.0%
43.2%
EPS (diluted)
$0.30
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRST
FRST
STIM
STIM
Q1 26
$45.6M
Q4 25
$80.9M
$41.8M
Q3 25
$41.0M
$37.3M
Q2 25
$43.2M
$38.1M
Q1 25
$58.7M
$32.0M
Q4 24
$38.8M
$22.5M
Q3 24
$37.3M
$18.5M
Q2 24
$35.7M
$16.4M
Net Profit
FRST
FRST
STIM
STIM
Q1 26
$7.3M
Q4 25
$29.5M
$-7.2M
Q3 25
$6.8M
$-9.0M
Q2 25
$2.4M
$-10.1M
Q1 25
$22.6M
$-12.7M
Q4 24
$-26.2M
$-12.7M
Q3 24
$1.2M
$-13.3M
Q2 24
$3.4M
$-9.8M
Gross Margin
FRST
FRST
STIM
STIM
Q1 26
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Operating Margin
FRST
FRST
STIM
STIM
Q1 26
Q4 25
44.8%
-12.1%
Q3 25
21.3%
-19.6%
Q2 25
6.9%
-21.1%
Q1 25
41.9%
-34.4%
Q4 24
-123.0%
-51.0%
Q3 24
-3.1%
-41.7%
Q2 24
7.8%
-51.7%
Net Margin
FRST
FRST
STIM
STIM
Q1 26
16.0%
Q4 25
36.5%
-17.2%
Q3 25
16.7%
-24.3%
Q2 25
5.6%
-26.6%
Q1 25
38.6%
-39.6%
Q4 24
-100.3%
-56.4%
Q3 24
3.3%
-72.0%
Q2 24
9.6%
-59.8%
EPS (diluted)
FRST
FRST
STIM
STIM
Q1 26
$0.30
Q4 25
$1.19
$-0.10
Q3 25
$0.28
$-0.13
Q2 25
$0.10
$-0.15
Q1 25
$0.92
$-0.21
Q4 24
$-0.95
$-0.34
Q3 24
$0.05
$-0.44
Q2 24
$0.14
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRST
FRST
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$159.9M
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$427.2M
$22.4M
Total Assets
$4.3B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRST
FRST
STIM
STIM
Q1 26
$159.9M
Q4 25
$143.6M
$28.1M
Q3 25
$63.9M
$28.0M
Q2 25
$94.1M
$11.0M
Q1 25
$57.0M
$20.2M
Q4 24
$64.5M
$18.5M
Q3 24
$77.3M
$20.9M
Q2 24
$66.6M
$42.6M
Total Debt
FRST
FRST
STIM
STIM
Q1 26
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Stockholders' Equity
FRST
FRST
STIM
STIM
Q1 26
$427.2M
Q4 25
$422.9M
$22.4M
Q3 25
$382.2M
$27.4M
Q2 25
$376.4M
$27.1M
Q1 25
$375.6M
$35.5M
Q4 24
$351.8M
$27.7M
Q3 24
$381.0M
$9.4M
Q2 24
$376.0M
$19.4M
Total Assets
FRST
FRST
STIM
STIM
Q1 26
$4.3B
Q4 25
$4.0B
$141.6M
Q3 25
$4.0B
$145.5M
Q2 25
$3.9B
$134.7M
Q1 25
$3.7B
$142.0M
Q4 24
$3.7B
$140.9M
Q3 24
$4.0B
Q2 24
$4.0B
$96.8M
Debt / Equity
FRST
FRST
STIM
STIM
Q1 26
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRST
FRST
STIM
STIM
Operating Cash FlowLast quarter
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRST
FRST
STIM
STIM
Q1 26
Q4 25
$10.8M
$908.0K
Q3 25
$-11.4M
$-785.0K
Q2 25
$-41.0M
$-3.5M
Q1 25
$34.4M
$-17.0M
Q4 24
$19.5M
$-8.6M
Q3 24
$6.1M
$-5.4M
Q2 24
$52.3M
$-5.0M
Free Cash Flow
FRST
FRST
STIM
STIM
Q1 26
Q4 25
$9.0M
$692.0K
Q3 25
$-899.0K
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$18.3M
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
FCF Margin
FRST
FRST
STIM
STIM
Q1 26
Q4 25
11.2%
1.7%
Q3 25
-2.4%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
47.3%
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Capex Intensity
FRST
FRST
STIM
STIM
Q1 26
Q4 25
2.1%
0.5%
Q3 25
0.3%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
3.1%
0.4%
Q3 24
0.0%
2.1%
Q2 24
0.0%
3.7%
Cash Conversion
FRST
FRST
STIM
STIM
Q1 26
Q4 25
0.36×
Q3 25
-1.67×
Q2 25
-16.82×
Q1 25
1.52×
Q4 24
Q3 24
4.93×
Q2 24
15.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRST
FRST

Net Interest Income$32.1M70%
Noninterest Income$13.6M30%

STIM
STIM

Segment breakdown not available.

Related Comparisons